Evonik Industries AG (ETR:EVK)
Germany
· Delayed Price · Currency is EUR | Market Cap | 7.46B |
| Revenue (ttm) | 13.72B |
| Net Income (ttm) | 157.00M |
| Shares Out | 466.00M |
| EPS (ttm) | 0.34 |
| PE Ratio | 47.41 |
| Forward PE | 9.33 |
| Dividend | 1.00 (6.28%) |
| Ex-Dividend Date | Jun 4, 2026 |
| Volume | n/a |
| Average Volume | 1,466,381 |
| Open | 15.95 |
| Previous Close | 15.93 |
| Day's Range | 15.80 - 16.45 |
| 52-Week Range | 12.49 - 18.42 |
| Beta | 0.53 |
| RSI | 46.67 |
| Earnings Date | Aug 4, 2026 |
About Evonik Industries AG
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and ... [Read more]
Financial Performance
In 2025, Evonik Industries AG's revenue was 14.07 billion, a decrease of -7.18% compared to the previous year's 15.16 billion. Earnings were 265.00 million, an increase of 19.37%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for EVK stock is "Hold." The 12-month stock price target is €17.44, which is an increase of 9.00% from the latest price.
News
Evonik Raises Guidance on Higher Prices, Cost Reductions
Evonik said it raised its guidance for the year on higher prices, higher sales volumes and cost reductions.
Evonik To Sell Pharma Ingredient Assets In Hanau To ProChem For Undisclosed Terms; Stock Up
BRUSSELS (dpa-AFX) - German specialty chemicals maker Evonik Industries AG (EVK.DE) announced on Friday that it is selling selected pharmaceutical ingredient production assets at its Hanau site in...
Evonik Industries (EVKIF) to Cut 3,200 Jobs Amid Restructuring Efforts
Evonik Industries (EVKIF) to Cut 3,200 Jobs Amid Restructuring Efforts
Evonik to cut 3,200 jobs worldwide by 2029, as it extends restructuring programme
Evonik Industries will cut 3,200 jobs worldwide by the end of 2029, including 2,150 positions in Germany, the German chemicals group said on Thursday.
EQS-AFR: Evonik Industries AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Evonik Industries AG / Preliminary announcement on the disclosure of financial statements Evonik Industries AG: Preliminary announcement of the publicat...
Evonik Industries AG Transcript: Investor update
Resilience, sustainability, and innovation are integrated to address global challenges and drive growth. Key initiatives include advanced biosolutions, green hydrogen, and circular economy solutions, supported by a restructured R&D organization and international hubs.
EQS-Adhoc: RAG-Stiftung: RAG-STIFTUNG LAUNCHES AN OFFERING OF BONDS EXCHANGEABLE INTO SHARES OF EVONIK INDUSTRIES AG
EQS-Ad-hoc: RAG-Stiftung / Key word(s): Capital measures / Other RAG-Stiftung: RAG-STIFTUNG LAUNCHES AN OFFERING OF BONDS EXCHANGEABLE INTO SHARES OF EVONIK INDUSTRIES AG 09-Jun-2026 / 07:41 CET/CEST ...
EQS-DD: Evonik Industries AG: Lauren Kjeldsen, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 08.06.2026 / 09:07 CET/CEST The issuer is solely responsi...
Evonik Industries AG Transcript: AGM 2026
The meeting addressed leadership changes, a challenging financial year, and a shift to a performance-based dividend policy. Strategic initiatives focus on innovation, cost discipline, and green transformation, with continued investment in growth areas.
Evonik Industries AG Earnings Call Transcript: Q1 2026
Q1 2026 adjusted EBITDA exceeded expectations at EUR 475 million, driven by strong Advanced Technologies and pre-buying effects, while free cash flow remained robust. Q2 EBITDA is guided to at least EUR 550 million, but risks from inflation and supply chain disruptions persist.
Evonik Industries AG Slides: Q1 2026
Evonik Industries AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 8, 2026.
Evonik Industries AG Quarterly report: Q1 2026
Evonik Industries AG has published its Q1 2026 quarterly earnings report on May 8, 2026.
Evonik Industries AG Earnings release: Q1 2026
Evonik Industries AG released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
Evonik Industries AG Slides: Company presentation
Evonik Industries AG has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
Evonik Industries AG Earnings release: Q4 2025
Evonik Industries AG released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.
Evonik Industries AG Annual report: Q4 2025
Evonik Industries AG has published its Q4 2025 annual report on March 4, 2026.
Evonik Industries AG Annual report: Q4 2025
Evonik Industries AG has published its Q4 2025 annual report on March 4, 2026.
Evonik Industries AG Slides: Q4 2025
Evonik Industries AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.
Evonik Industries AG Slides: Sustainability presentation
Evonik Industries AG has posted slides in relation to its latest quarterly earnings report, which was published on March 4, 2026.
Evonik Industries AG Slides: Investor presentation
Evonik Industries AG has posted slides in relation to its latest quarterly earnings report, which was published on March 4, 2026.
Evonik Industries AG Earnings Call Transcript: Q4 2025
Delivered solid 2025 results with EUR 1.9 billion adjusted EBITDA and strong cash flow. 2026 guidance targets stable earnings amid persistent weak demand, cost savings, and a new flexible dividend policy. Regulatory and market changes, especially in methionine and Oxeno, will shape performance.
Evonik Industries AG Earnings release: Q4 2025
Evonik Industries AG released its Q4 2025 earnings on February 5, 2026, summarizing the period's financial results.
Evonik Industries AG Slides: Q4 2025
Evonik Industries AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 5, 2026.
Evonik Industries AG Earnings Call Transcript: Q3 2025
Q3 results were weak, leading to a revised full-year EBITDA guidance of EUR 1.9 billion, but confidence remains in meeting targets due to strong healthcare and Animal Nutrition recovery. Structural cost savings, new plant ramp-ups, and the SYNEQT carve-out are expected to support future performance despite ongoing market challenges.
Evonik Industries AG Quarterly report: Q3 2025
Evonik Industries AG has published its Q3 2025 quarterly earnings report on November 4, 2025.